Eubiologics Ltd.

EuBiologics develops and manufactures cholera, bacterial, and pandemic vaccines in Korea, offering inactivated oral cholera shots, recombinant protein vaccines, adjuvants, and full contract R&D/CMR services to expand global vaccine access.

Headquarters: South Korea (KOR)

Eubiologics Ltd. Logo
Company Profile
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
206650 Eubiologics Ltd.
Cap: 433.6B
EQUITY KOE KRW KR7206650004 Active
📈
Home Login